Offering a selection of packaging options and concentrations (160, 240, 300, 320 and 350), OptiMARK (gadoversetamide injection) is one of the first MRI contrast agent approved for use with power injection. Using OptiMARK with the OptiStar LE power injector at rates of 1 to 2 ml per second image quality, diagnostic accuracy, reproducibility, accurate timing of bolus and a tight bolus (when used with saline flush at the same flow rate as the contrast media), said Tyco. It is available in glass vials in a range of sizes or easy-to-use Ultraject prefilled syringes.
Technology | June 05, 2006
MRI Media Approved for Use with Power Injection
Technology | Contrast Media | July 15, 2019
July 15, 2019 — The U.S.
Videos | Contrast Media | June 28, 2019
Feature | Contrast Media | May 31, 2019 | Dave Fornell, Editor
Iodine-based contrast agents used in c
News | Contrast Media | May 09, 2019
Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety and...
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
News | Contrast Media | January 19, 2018
Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Diagnostic Imaging Contrast Agents
Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced renal toxicity....
News | Contrast Media | September 07, 2017
The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory...
News | Contrast Media | August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
News | Contrast Media | July 18, 2017
Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix (meglumine and...